Table 2.
Variables on follow-up visit (6 months after treatment) | Group 1 patients without post-COVID | Group 2 patients with post-COVID | p-value group 1 vs. group 2 (visit 2) |
---|---|---|---|
Leukocytes, µL-1 (median, range) | 7.81 (3.35–15.81) | 6.05 (4.04–10.73) | 0.077 |
p value (visit 1 vs. visit 2) | 0.020 | 0.300 | |
Platelets, x 1000 µL-1 (median, range) | 367 (142–489) | 223 (126–412) | 0.004 |
p value (visit 1 vs. visit 2) | 0.004 | 0.124 | |
C-reactive protein, mg/dl (median, range) | 1.69 (1.00-93.7) | 2.05 (0.86–29.2) | 0.649 |
p value (visit 1 vs. visit 2) | 0.009 | 0.012 | |
Procalcitonin, (median, range) | 0.23 (0.02–0.25) | 0.05 (0.04–0.05) | 0.628 |
p value (visit 1 vs. visit 2) | 0.003 | 0.654 | |
Ferritin µg/L, (median, range) | 367.5 (12-1031) | 292.75 (9.6–2556) | 0.862 |
p value (visit 1 vs. visit 2) | 0.161 | 0.441 | |
IL-6 pg/ml, (median, range) | 7.95 (1.5–15.8) | 2.25 (1.5-634.5) | 0.570 |
p value (visit 1 vs. visit 2) | 0.108 | 0.236 |
Abbreviations: COVID-19 - Coronavirus disease 19, IL-6 – interleukin 6.